fbpx
  • Topics
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Enterprise & SaaS
    • Gadgets & Electronics
    • Health & Bio
    • FinTech
    • IoT
    • Transportation & Logistics
    • Marketplaces & E-commerce
    • Ecosystem
    • Robotics
    • Investments
    • EdTech
    • Featured
  • Deals
    • Private Equity
    • Venture Capital
    • IPO & Markets
  • Interviews
    • Startup Investing
    • Fundraising
    • Product Launching
  • MORE
    • Events
    • Startups Advice
  • Submit an Article
  • REGISTER
  • login
No Result
View All Result
No Result
View All Result
Home Health & Bio

One BioMed Singapore- Offering Cutting-Edge Medical Diagnostic Platform

AsiaTechDaily Writer by AsiaTechDaily Writer
06 August 2019
in Health & Bio
0
OneBioMed Singapore
83
SHARES
Share on FacebookShare on Twitter
Bookmark (0)

Please login to bookmark

No account yet? Register

One BioMed Singapore, a medical diagnostic company is a spin-off of A*Star’s (Agency for Science, Technology, and Research) IME (Institute of Microelectronics). One BioMed Singapore has developed a POC (point-of-care) diagnostic platform by using two patented technologies- a silicon biophotonics sensor and a chemistry-based nucleic acidic extraction. One BioMed aims to address global health needs.

The company was founded by Dr. Mi-Kyoung Park. She is a Ph.D. Chemist with twelve years of academic and industrial research experience in polymer chemistry, surface science, biotechnology, and nanotechnology. She is also an expert in in-virto diagnostic devices for infectious disease and cancer detection. She has done her higher studies from the University of Houston.

One BioMed Singapore- A Step Forward To Improve Medical Diagnostic In Healthcare

Until now, early disease detection using molecular diagnostics was limited in both speed and cost.   With one of its kind medical diagnostic platform in One BioMed Singapore, the doctors and patients do not need to wait for days for samples to be sent to a central laboratory for tests.

One BioMed Singapore offers cutting-edge, digital-health, MDx (molecular diagnostic) platform technologies that are poised to revolutionize early infectious disease detection at POC. The company’s technology enables instantaneous detection of both viral and bacterial infections in less than 30 minutes. All this is done in a fully automated format which is at par in terms of the cost of a single MDx test in a central laboratory. This gives physicians a tool to precisely diagnose a panel of diseases based solely on symptoms.

Funding-All Sorted!

One BioMed Singapore has recently announced that they have been able to raise US$5 million funding. The funding round was led by BioPath Ventures and US-based Arch Venture Partners besides the participation from SEEDS Capital, Singapore’s investment arm.

The Road Map Ahead

The first flagship product of the company is a simple, affordable, and cohesive diagnostic device that enables faster detection of infectious diseases based on a unique silicon biophotonic technology platform. This automatic sample preparation device purifies and isolates nucleic acids from a variety of samples, which is the first step in most of the clinical diagnostic and molecular biological technologies.

OneBioMed Singapore

One BioMed Singapore will be using the funds to commercialize its first product. According to the company sources, its sample preparation device is the foundation upon which it will build the next platforms. They plan to do this through the integration of molecular diagnostic tools that will include silicon biophotonics sensing technology for POC infectious disease detection.

Get in touch with the team today!

Keep an eye on this innovative startup and many more such startups.

Image Source –One BioMed Singapore Official Website, pixabay.com

Tags: affordablecancer detectioncohesive diagnosticcost effective treatmentdigital-health technologyearly disease detectionilicon biophotonics sensorin-virto diagnostic devicesinfectitious ddiseases treatmentmedical diagnosismedical diagnostic companymolecular biological technologiesmolecular diagnosticsnucleic acidic extractionOne BioMed SingaporePOC infectious disease detectionsimpleSingaporeviral and bacterial infection detection in less than 30 minutes
Previous Post

theAsianparent Singapore- An Online Platform Making Parenting Easy

Next Post

Asenso Singapore- Fintech Startup Providing an Integrated Platform For Asian MSMEs

Related Posts

edit post
Qritive
Featured

Healthcare AI startup Qritive nets $7.5m to expand into new markets

January 31, 2023
edit post
Holmusk
Featured

Healthtech startup Holmusk raises $45m to continue rapid expansion

January 23, 2023
edit post
HD
Featured

Thai healthcare, surgery marketplace HD raises $6m in funding

January 4, 2023
edit post
Doctor Anywhere
Health & Bio

Regional healthtech Doctor Anywhere acquires Asian Healthcare Specialists

December 31, 2022
edit post
Speedoc
Featured

Singapore’s Speedoc raises $28m in pre-Series B funding

November 8, 2022
edit post
Imagoworks
Health & Bio

Korean startup Imagoworks launches AI-based web dental CAD 3Dme Crown

November 8, 2022
Next Post
edit post
Asenso Singapore

Asenso Singapore- Fintech Startup Providing an Integrated Platform For Asian MSMEs

Discussion about this post

No Result
View All Result

Follow Us

FREE NEWSLETTER




Copyright © 2023 AsiaTechDaily.com| About Us | Seed accelerator| Terms of Use| Privacy Policy| Cookie Policy Contact : [email protected] | DMCA.com Protection Status | trusted by Wimgo

No Result
View All Result
  • Topics
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Enterprise & SaaS
    • Gadgets & Electronics
    • Health & Bio
    • FinTech
    • IoT
    • Transportation & Logistics
    • Ecosystem
    • Marketplaces & E-commerce
    • Robotics
    • Investments
    • Featured
  • Deals
    • Private Equity
    • Venture Capital
    • IPO & Markets
  • Interviews
    • Startup Investing
    • Fundraising
    • Product Launching
  • MORE
    • Events
    • Startups Advice
  • Submit an Article
  • Forums
  • Jobs
  • REGISTER
  • Login

Copyright © 2023 AsiaTechDaily.com| About Us | Seed accelerator| Terms of Use| Privacy Policy| Cookie Policy Contact : [email protected] | DMCA.com Protection Status | trusted by Wimgo

We hope you enjoy our content, May you please give us Feedback regarding our website!

Single Post Feedback